X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/06/2924922/0/en/AC-Immune-Reports-Second-Quarter-2024-Financial-Results-and-Provides-a-Corporate-Update.html
https://www.fiercebiotech.com/biotech/ac-immune-presents-early-results-potential-landmark-alzheimers-drug
https://www.globenewswire.com/news-release/2024/07/31/2921866/0/en/AC-Immune-Unveils-Novel-Therapeutic-Antibody-Drug-Conjugate-ADC-Technology-for-Improved-Efficacy-in-Neurodegenerative-Diseases-at-AAIC-2024.html
https://www.globenewswire.com/news-release/2024/07/25/2918683/0/en/AC-Immune-s-ACI-35-030-now-JNJ-2056-Granted-FDA-Fast-Track-Designation-for-Alzheimer-s-Disease.html
https://www.globenewswire.com/news-release/2024/07/16/2913613/0/en/AC-Immune-Showcasing-its-Novel-Morphomer-Antibody-Drug-Conjugate-morADC-Platform-for-the-Treatment-of-Neurodegenerative-Diseases-at-AAIC-2024.html
https://www.globenewswire.com/news-release/2024/05/28/2888855/0/en/AC-Immune-to-Present-at-the-Jefferies-Global-Healthcare-Conference-in-June-2024.html
https://www.biopharmadive.com/news/takeda-alzheimers-ac-immune-immunotherapies/715913/
https://www.globenewswire.com/news-release/2024/05/13/2880203/0/en/AC-Immune-Reports-First-Quarter-2024-Financial-Results-and-Provides-a-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/13/2880195/0/en/AC-Immune-and-Takeda-Sign-Exclusive-Option-and-License-Agreement-for-Active-Immunotherapy-Targeting-Amyloid-Beta-for-Alzheimer-s-Disease.html
Market Place
Share 
